These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1126 related items for PubMed ID: 19509324

  • 1. Assessment and management of rheumatoid arthritis.
    Haraoui B.
    J Rheumatol Suppl; 2009 Jun; 82():2-10. PubMed ID: 19509324
    [Abstract] [Full Text] [Related]

  • 2. Unresolved issues in identifying and overcoming inadequate response in rheumatoid arthritis: weighing the evidence.
    Cohen SB, Cohen MD, Cush JJ, Fleischmann RM, Mease PJ, Schiff MH, Simon LS, Weaver AL.
    J Rheumatol Suppl; 2008 Feb; 81():4-30; quiz 31-4. PubMed ID: 19193621
    [Abstract] [Full Text] [Related]

  • 3. Unmet needs in rheumatoid arthritis.
    Bykerk V.
    J Rheumatol Suppl; 2009 Jun; 82():42-6. PubMed ID: 19509330
    [Abstract] [Full Text] [Related]

  • 4. Early rheumatoid arthritis -- is there a window of opportunity?
    Cush JJ.
    J Rheumatol Suppl; 2007 Nov; 80():1-7. PubMed ID: 17985417
    [Abstract] [Full Text] [Related]

  • 5. Treatment of early rheumatoid arthritis: concepts in management.
    Haraoui B, Pope J.
    Semin Arthritis Rheum; 2011 Apr; 40(5):371-88. PubMed ID: 21295822
    [Abstract] [Full Text] [Related]

  • 6. Rheumatoid arthritis treatment and monitoring of outcomes--where are we [corrected] in 2007?
    Yazici Y, Abramson SB.
    Bull NYU Hosp Jt Dis; 2007 Apr; 65(4):300-5. PubMed ID: 18081549
    [Abstract] [Full Text] [Related]

  • 7. Management of early rheumatoid arthritis.
    Suresh E.
    J Assoc Physicians India; 2007 May; 55():355-62. PubMed ID: 17844697
    [Abstract] [Full Text] [Related]

  • 8. Drug management of early rheumatoid arthritis - 2008.
    Sokka T, Mäkinen H.
    Best Pract Res Clin Rheumatol; 2009 Feb; 23(1):93-102. PubMed ID: 19233049
    [Abstract] [Full Text] [Related]

  • 9. Aspects of early arthritis. Traditional DMARD therapy: is it sufficient?
    Machold KP, Nell VP, Stamm TA, Smolen JS.
    Arthritis Res Ther; 2006 Feb; 8(3):211. PubMed ID: 16719936
    [Abstract] [Full Text] [Related]

  • 10. Progression in early rheumatoid arthritis.
    Combe B.
    Best Pract Res Clin Rheumatol; 2009 Feb; 23(1):59-69. PubMed ID: 19233046
    [Abstract] [Full Text] [Related]

  • 11. Performance of a rheumatoid arthritis records-based index of severity.
    Ting G, Schneeweiss S, Katz JN, Weinblatt ME, Cabral D, Scranton RE, Solomon DH.
    J Rheumatol; 2005 Sep; 32(9):1679-87. PubMed ID: 16142860
    [Abstract] [Full Text] [Related]

  • 12. Minimal disease activity, remission, and the long-term outcomes of rheumatoid arthritis.
    Wolfe F, Rasker JJ, Boers M, Wells GA, Michaud K.
    Arthritis Rheum; 2007 Aug 15; 57(6):935-42. PubMed ID: 17665487
    [Abstract] [Full Text] [Related]

  • 13. Initial management of rheumatoid arthritis.
    Gramling A, O'Dell JR.
    Rheum Dis Clin North Am; 2012 May 15; 38(2):311-25. PubMed ID: 22819086
    [Abstract] [Full Text] [Related]

  • 14. Utilization of biologic agents in rheumatoid arthritis in the United States: analysis of prescribing patterns in 16,752 newly diagnosed patients and patients new to biologic therapy.
    Yazici Y, Shi N, John A.
    Bull NYU Hosp Jt Dis; 2008 May 15; 66(2):77-85. PubMed ID: 18537774
    [Abstract] [Full Text] [Related]

  • 15. Patients with moderate rheumatoid arthritis (RA) achieve better disease activity states with etanercept treatment than patients with severe RA.
    Keystone E, Freundlich B, Schiff M, Li J, Hooper M.
    J Rheumatol; 2009 Mar 15; 36(3):522-31. PubMed ID: 19228659
    [Abstract] [Full Text] [Related]

  • 16. Remission by composite scores in rheumatoid arthritis: are ankles and feet important?
    Kapral T, Dernoschnig F, Machold KP, Stamm T, Schoels M, Smolen JS, Aletaha D.
    Arthritis Res Ther; 2007 Mar 15; 9(4):R72. PubMed ID: 17662115
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological management of early rheumatoid arthritis--does combination therapy improve outcomes?
    Dougados M, Smolen JS.
    J Rheumatol Suppl; 2002 Nov 15; 66():20-6. PubMed ID: 12435165
    [Abstract] [Full Text] [Related]

  • 18. Starting a disease modifying antirheumatic drug or a biologic agent in rheumatoid arthritis: standards of practice for RA treatment.
    Wolfe F, Rehman Q, Lane NE, Kremer J.
    J Rheumatol; 2001 Jul 15; 28(7):1704-11. PubMed ID: 11469485
    [Abstract] [Full Text] [Related]

  • 19. Assessment of anti-TNF-alpha efficacy in rheumatoid arthritis: is 3 months sufficient?
    Pocock JM, Vasconcelos JC, Ostör AJ.
    Rheumatology (Oxford); 2008 Jul 15; 47(7):1073-6. PubMed ID: 18503089
    [Abstract] [Full Text] [Related]

  • 20. Improving the routine management of rheumatoid arthritis: the value of tight control.
    Mease PJ.
    J Rheumatol; 2010 Aug 01; 37(8):1570-8. PubMed ID: 20595287
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.